Estrella Immunopharma Inc. Common Stock (ESLA)
Stock · NASDAQ · Health Care
$0.4299as of 10/16/2026
Price chart
Active signals
ESLA Signal Track Record
How signals performed across all stocks →What ESLA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 37 | -6.3% | 38% | September 4, 2026 |
| Bollinger Band Breakout | 27 | -0.2% | 48% | April 6, 2026 |
| Bollinger Band Breakdown | 17 | +0.8% | 53% | September 17, 2026 |
| 200-Day Moving Average TouchActive now | 16 | -2.6% | 31% | May 5, 2026 |
| Any 20-session window (baseline) | -1.4% | 44% |
Computed by MarketWall from daily closing prices since June 29, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ESLA
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in Phase I/II clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Website
- www.estrellabio.com/
Fundamentals
- 1-day range
- $0.4208$0.51
- Market cap
- $32.10M
- P/E (trailing)
- —
- P/E (forward)
- -1.41
- EPS (trailing)
- $-0.25
- Dividend yield
- —
- Beta
- 0.98
- Avg. volume
- 1.34M
Forecasts
1 analyst ratings
Estrella Immunopharma Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ESLAEstrella Immunopharma Inc. Common Stock$0.43▼ 19.63%Market cap $32.10MP/E —$0.295$3.15
- ENGNWenGene Therapeutics Inc. Warrants$0.17▲ 1.19%Market cap $33.75MP/E —$0.1113$4.2
- ALGSAligos Therapeutics Inc. Common Stock$4.86▼ 9.83%Market cap $34.10MP/E —$3.98$13.69
- QNCXQuince Therapeutics Inc. Common Stock$32.03▼ 3.61%Market cap $30.04MP/E —$15.1$910
- CVMCel-Sci Corporation Common Stock$1.79▲ 2.87%Market cap $28.14MP/E —$0.89$10.24
- DYAIDyadic International Inc. Common Stock$0.41▼ 2.38%Market cap $37.17MP/E —$0.3401$1.6
- ELUTElutia Inc. Class A Common Stock$0.794▲ 0.63%Market cap $38.95MP/E 0.67$0.5$1.39
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ESLA Estrella Immunopharma Inc. Common Stock | $32.10M | — | $0.43 | ▼ 19.63% | $0.295$3.15 |
| ENGNW enGene Therapeutics Inc. Warrants | $33.75M | — | $0.17 | ▲ 1.19% | $0.1113$4.2 |
| ALGS Aligos Therapeutics Inc. Common Stock | $34.10M | — | $4.86 | ▼ 9.83% | $3.98$13.69 |
| QNCX Quince Therapeutics Inc. Common Stock | $30.04M | — | $32.03 | ▼ 3.61% | $15.1$910 |
| CVM Cel-Sci Corporation Common Stock | $28.14M | — | $1.79 | ▲ 2.87% | $0.89$10.24 |
| DYAI Dyadic International Inc. Common Stock | $37.17M | — | $0.41 | ▼ 2.38% | $0.3401$1.6 |
| ELUT Elutia Inc. Class A Common Stock | $38.95M | 0.67 | $0.794 | ▲ 0.63% | $0.5$1.39 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Reported Earlier, Estrella’s EB103 Dosed Twice Three Weeks Apart In First Dose-Expansion Patient At Recommended Phase II Dose, No Treatment-Related SAEs; Dose-Escalation Delivered 100% Month 1 Complete Response In High-Dose Cohortbenzinga · 10/16/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/9/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 10/9/2026
Insider Activity
Insider Actions →- Liu Cheng · August 25, 2026 · Option Exercise100.0K @ $0.815
- Xu Jiandong · August 18, 2026 · Option Exercise100.0K @ $0.815
Institutional Ownership
March 31, 2026
- Total shares held
- 5.11M
- Total value held
- $5.42M
- Institutional holders
- 15
- Unknown4.10M
- Unknown382.5K
- Unknown264.4K
- Unknown157.5K
- Unknown62.8K
- Unknown43.3K
- Unknown39.9K
- Unknown19.6K
- Unknown16.9K
- Unknown15.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
ESLA Among 12 Health Care Stocks Moving in Friday Pre‑Market
ESLA was one of 12 health‑care shares that saw movement in Friday’s pre‑market session. The stock traded with a volume spike and an RSI of 21.5, indicating a potential shift in interest. It remains near its 17‑touch support level of $0.74. The move comes as the broader health‑care sector shows early activity ahead of the trading day.
ESLA Among 12 Health Care Stocks Moving in Friday Pre‑Market. ESLA was one of 12 health‑care shares that saw movement in Friday’s pre‑market session. The stock traded with a volume spike and an RSI of 21.5, indicating a potential shift in interest. It remains near its 17‑touch support level of $0.74. The move comes as the broader health‑care sector shows early activity ahead of the trading day.